These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11651263)

  • 1. Is the practice of offering finder's fees for subject recruitment appropriate? Is the practice widespread or unique to my institution? What is the proper role of the IRB? What is the role of the institution?
    IRB; 1990; 12(4):6. PubMed ID: 11651263
    [No Abstract]   [Full Text] [Related]  

  • 2. Finder's fees may compromise the provider-patient relationship.
    McGough H
    IRB; 1991; 13(1-2):23. PubMed ID: 11653979
    [No Abstract]   [Full Text] [Related]  

  • 3. Do medical student research subjects need special protection?
    Christakis N
    IRB; 1985; 7(3):1-4. PubMed ID: 11649647
    [No Abstract]   [Full Text] [Related]  

  • 4. Against special protections for medical students.
    Angoff NR
    IRB; 1985; 7(5):9-10. PubMed ID: 11649754
    [No Abstract]   [Full Text] [Related]  

  • 5. IRB policies regarding finder's fees and role conflicts in recruiting research participants.
    Wolf LE
    IRB; 2009; 31(1):14-9. PubMed ID: 19241735
    [No Abstract]   [Full Text] [Related]  

  • 6. Reviewing subject recruitment: new rules from Rockville.
    McMahon FG
    IRB; 1988; 10(3):6-7. PubMed ID: 11651911
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug trials hide conflicts for doctors.
    Eichenwald K; Kolata G
    N Y Times Web; 1999 May; ():1, 34. PubMed ID: 11648114
    [No Abstract]   [Full Text] [Related]  

  • 8. Why I oppose drug company payment of physician/investigators on a per patient/subject basis.
    Roizen R
    IRB; 1988; 10(1):9-10. PubMed ID: 11658990
    [No Abstract]   [Full Text] [Related]  

  • 9. Coercion in the recruitment and retention of human research subjects, pharmaceutical industry payments to physician-investigators, and the moral courage of the IRB.
    DeRenzo EG
    IRB; 2000; 22(2):1-5. PubMed ID: 11883465
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychology ethics down under: a survey of student subject pools in Australia.
    Diamond MR; Reidpath DD
    Ethics Behav; 1992; 2(2):101-8. PubMed ID: 11651251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical responsibilities of physicians in their dealings with pharmaceutical companies.
    Royal College of Physicians and Surgeons of Canada. Biomedical Ethics Committee
    Ann R Coll Physicians Surg Can; 1990 Jan; 23(1):45-8. PubMed ID: 11650305
    [No Abstract]   [Full Text] [Related]  

  • 12. Which subjects should an IRB protect? Two moral models.
    Lackey DP
    IRB; 1982; 4(7):5-6. PubMed ID: 11651703
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperbaric research at Duke University--ethical considerations.
    Bennett PB; Kylstra JA
    Forsvarsmedicin; 1973; 9(3):373-8. PubMed ID: 11661280
    [No Abstract]   [Full Text] [Related]  

  • 14. Bounty-hunting and finder's fees.
    Christensen JA; Orlowski JP
    IRB; 2005; 27(3):16-9. PubMed ID: 16021797
    [No Abstract]   [Full Text] [Related]  

  • 15. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 16. Research fraud, misconduct, and the IRB.
    Hilgartner S
    IRB; 1990; 12(1):1-4. PubMed ID: 11651971
    [No Abstract]   [Full Text] [Related]  

  • 17. Considering behavioral and biomedical research on detainees in the mental health unit of an urban mega-jail.
    Brakel SJ
    N Engl J Crim Civ Confin; 1996; 22(1):1-27. PubMed ID: 11660427
    [No Abstract]   [Full Text] [Related]  

  • 18. Bill of rights for research subjects.
    Prentice ED; Reitemeier PJ; Antonson DL; Kelso TK; Jameton A
    IRB; 1993; 15(2):7-9. PubMed ID: 11651568
    [No Abstract]   [Full Text] [Related]  

  • 19. Researchers must inform subjects about financial incentives for study.
    Maloney DM
    Hum Res Rep; 1999 Aug; 14(8):6. PubMed ID: 11657806
    [No Abstract]   [Full Text] [Related]  

  • 20. For whose protection? Another moral model.
    Newton LH
    IRB; 1983; 5(3):9-10. PubMed ID: 11649519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.